Paul Wicks
Independent Consultant @ Wicks Digital Health Ltd.
London, United Kingdom
Paul Wicks is a seed investor at Wicks Digital Health Ltd. in London focused on Software and Wellness. Paul Wicks, Ph.D., is a strategic advisor and independent consultant who helps digital health and life science companies turn data into evidence, evidence into influence, and influence into impact. He has supported over 40 organizations including AstraZeneca, Ada Health, Biogen, Click Therapeutics, and Woebot.Previously, Paul spent 13 years as VPof R&D at PatientsLikeMe, building one of the world’s largest patient communities and pioneering decentralized trials, digital biomarkers, and real-world evidence. He has authored over 200 peer-reviewed papers and served on editorial boards of journals including the BMJ, Digital Biomarkers, and BMC Medicine.A neuropsychologist by training, Paul completed his Ph.D. at King’s College London and a postdoc on the psychology of Parkinson’s disease. His work has been featured by BBC, CNN, and The New York Times. He was named MIT Technology Review’s “Humanitarian of the Year” in 2011 and is a TED Fellow and FLIER alumnus of the Academy of Medical Sciences. He is an honorary Professor at the University of Birmingham.
- Total investments:
- 17
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Paul Wicks invests in
Stages Paul Wicks invests in
Countries Paul Wicks invests in
Round sizes
Round size
- Seed
- $3M–$6.6M
- Pre-Seed
- $539k–$1M
- Series A
- $6.7M–$11M
Investment Focus
Industry
- Software 3 (18%)
- Wellness 3 (18%)
- E-Commerce 3 (18%)
- Health Care 3 (18%)
- Artificial Intelligence 3 (18%)
Stage
- Seed 10 (59%)
- Pre-Seed 4 (24%)
- Series A 2 (12%)
- Grant 1 (6%)
Country
- United Kingdom 11 (65%)
- United States 2 (12%)
- Japan 1 (6%)
- Sweden 1 (6%)
- Belgium 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Epiminds develops multi-agent AI systems to run marketing end-to-end. | $6.6M / Seed / Oct 14, 2025 | |
|
|
Scooch is a pet wellness platform that offers health supplements for dogs. | Seed / Mar 18, 2025 | |
|
|
We are a research-led applied AI team advancing the future operating systems of AI. Traditional, fragmented AI stacks are struggling to scale under the demands of production, governance, and security, creating barriers to reliable, enterprise-grade AI deployment.With deep expertise spanning carrier and data centre architecture to applied AI andagent orchestration, we close that gap to deliver production-scale, compliant systems for enterprises operating with high-value, high-risk data across space, retail, media, and entertainment – embedding ethics, governance, and responsible AI practices at every stage. | $4.7M / Seed / Dec 31, 2024 | |
|
|
MAGIC is the UK's first AI Home Gym that helps people get personally trained by the world’s best athletes in their own home. | $5M / Seed / Nov 25, 2024 | |
|
|
Kuai Commerce is a social commerce solutions for brand acceleration. | Seed / Jul 26, 2024 | |
|
|
Recurse ML is built for enterprise environments, it integrates smoothly with your existing systems. | $3.2M / Seed / Jul 10, 2024 | |
|
|
Polari Labs is enhancing anorectal health and removing obstacles to intimacy. | $539K / Pre-Seed / Jun 27, 2024 | |
|
|
Warden is the tech-led AI auditor that helps platforms demonstrate AI fairness and compliance. Our platform continuously audits AI systems and provides transparency to customers with real-time dashboards and reports. We work with leading AI-powered platforms to build trust, drive adoption, and deploy AI with confidence. | Pre-Seed / Jun 01, 2024 | |
|
|
Unibloom is a data-driven predictive platform that aligns the best financial and commercial outcomes with important climate initiatives and optimal resource allocation. | $818K / Pre-Seed / May 14, 2024 | |
|
|
Our goal is to make Happl the leading People Experience platform for businesses across the globe. We want every manager to feel empowered to engage and support their teams, to make sure employees feel like they belong. | $3M / Seed / Apr 08, 2024 | |
| See all 17 investments → | |||
Co-Investors
About Wicks Digital Health Ltd.
We help digital health companies generate evidence, awareness, and revenue.
Wicks Digital Health Ltd. Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Paul Wicks
Independent Consultant
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Paul Wicks invest in?
Paul Wicks invests primarily in Software, Wellness and E-Commerce startups, most often at Seed and Pre-Seed stage. Most of the 17 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Paul Wicks's check size?
Paul Wicks typically joins rounds of $3M–$6.6M at Seed, $539k–$1M at Pre-Seed and $6.7M–$11M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Paul Wicks participates in.
When did Paul Wicks last invest?
The most recent investment recorded for Paul Wicks closed in Oct 2025. Shizune tracks 17 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!